Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319225 · ClinicalTrials.gov registry record
Examining the Distal Gut Microbiome After Spinal Cord Injury
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 5
- Enrollment target
NCT03319225 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 5 participants.
The verdict
NCT03319225 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome are related to gastrointestinal dysfunction in persons with Spinal Cord Injury and Non-Disabled Controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2018-01-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319225
The ClinicalTrials.gov registry entry for NCT03319225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03319225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03319225 about?
NCT03319225 is a clinical study titled "Examining the Distal Gut Microbiome After Spinal Cord Injury". The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome ar...
What is the current status of trial NCT03319225?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2017-12-18. Estimated completion is 2018-01-09.
Who is sponsoring clinical trial NCT03319225?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.